SAN DIEGO --(BUSINESS WIRE)--Jan. 24, 2022-- DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its fourth quarter and full year 2021 financial results after market close on Thursday, February 10, 2022 . Management will hold a conference call to review the company's fourth quarter

SAN DIEGO --(BUSINESS WIRE)--Jan. 10, 2022-- DexCom, Inc. (Nasdaq: DXCM), the leader in real-time continuous glucose monitoring (“CGM”), today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2021 to be approximately $698 million , an increase of 23%

SAN DIEGO --(BUSINESS WIRE)--Jan. 4, 2022-- DexCom, Inc. (NASDAQ:DXCM) today announced that Kevin Sayer , Chairman, President and Chief Executive Officer, will present an update on the company at the 40 th annual J.P. Morgan Healthcare Conference on January 10, 2022 .